Pfizer, UN-backed Medicines Patent Pool in advanced talks for Covid-19 pill

A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration. Credit: Reuters File Photo

Pfizer Inc and United Nations-backed Medicines Patent Pool (MPP) are in advanced talks on a licensing agreement that would allow qualified third parties to manufacture and supply the US drugmaker's oral antiviral pill candidate, pending regulatory nod, the MPP told Reuters.

Check out DH's latest videos: